Possible new focus for 2025 (National Cancer Institute)
- Tackling the Emergence of Early-Onset Cancers in Young Adults
- Approaching Cancer as a Disease That Affects the Entire Body
- Alleviating Financial Toxicity for Cancer Survivors and Caregivers
- Expanding the Utility of Cancer-Targeting Vaccines
2024
Give Kids a Chance Act of 2024: September 23, 2024, at 4:00 pm, the U.S. House of Representatives passed the Give Kid a Chance Act, HR 3433.
The Give Kids a Chance Act ensures that kids with cancer will have studies of combinations or new cancer arugs. This is important because finding new combinations of cancer drugs is the best wav to find new cures for kids. The Give Kids a Chance Act also brought forth the Creating Hope Reauthorization Act, reauthorizing the priority review voucher program, an incentive program that has resulted in over 60 new drugs for seriously ill kids. Vouchers sell for about $100 million. The Innovations in Pediatric Drugs Act is also part of the Give Kids a Chance Act, increasing funding for pediatric clinical studies at the National Institutes of Health (NIH) and imposing monetary penalties when companies fail to complete their required pediatric drug studies.